Milwaukee, WISCONSIN4 Active Studies

Leukemia Clinical Trials in Milwaukee, WISCONSIN

Find 4 actively recruiting leukemia clinical trials in Milwaukee, WISCONSIN. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
364
Enrolling

Recruiting Leukemia Studies in Milwaukee

RecruitingMilwaukee, WISCONSINNCT04835584

KRT-232 and TKI Study in Chronic Myeloid Leukemia

This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with Ph+ Chronic Myeloid Leukemia (CML) who have relapsed or are refractory or intolerant to ...

109 participants
Kartos Therapeutics, Inc.
View Study Details
RecruitingMilwaukee, WISCONSINNCT06179511

Study of AZD9829 in CD123+ Hematological Malignancies

This is a modular, multicentre, open-label, Phase I/II, dose-setting study. AZD9829 will be administered intravenously as monotherapy or in combination in participants with CD123 positive hematologica...

104 participants
AstraZeneca
View Study Details
RecruitingMilwaukee, WISCONSINNCT05143840

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

This study is a multicenter Phase 2, non-randomized, open-label single-group frontline study administering asciminib in patients with newly diagnosed Chronic Myeloid Leukemia-Chronic Phase (CML-CP). T...

100 participants
Augusta University
View Study Details
RecruitingMilwaukee, WISCONSINNCT04838041

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

This is a single arm phase II study that will enroll a minimum of 47 subjects with a maximum of 51. All patients will have a confirmed diagnosis of chronic phase chronic myeloid Leukemia and must have...

51 participants
Medical College of Wisconsin
View Study Details

About Leukemia Clinical Trials in Milwaukee

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Milwaukee, WISCONSIN. These studies are seeking a combined 364 participants. Research is being sponsored by Kartos Therapeutics, Inc., AstraZeneca, Augusta University and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Milwaukee — FAQ

Are there leukemia clinical trials in Milwaukee?

Yes, there are 4 leukemia clinical trials currently recruiting in Milwaukee, WISCONSIN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Milwaukee?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you about next steps.

Are clinical trials in Milwaukee free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Milwaukee studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Milwaukee are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov